...
首页> 外文期刊>Human psychopharmacology: clinical and experimental >Thyroid structure and function in long‐term lithium‐treated and lithium‐na?ve bipolar patients
【24h】

Thyroid structure and function in long‐term lithium‐treated and lithium‐na?ve bipolar patients

机译:在长期甲状腺结构和功能锂和锂钠治疗应承担的吗?病人

获取原文
获取原文并翻译 | 示例

摘要

Abstract Objective The aim of the study was to compare the structure and function of the thyroid in patients with bipolar disorder (BD) receiving long‐term lithium treatment, with BD patients never receiving lithium. Methods Ninety‐eight patients (68 female and 30 male), aged 62 ± 13 years, receiving lithium for 3–47 years (mean 19 ± 10 years), and 39 patients (27 female and 12 male), aged 57 ± 10 years, receiving other mood‐stabilizing drugs but never treated with lithium, were included. The thyroid‐stimulating hormone (TSH), free triiodothyronine (fT3), and free thyroxine (fT4) were estimated, and the ultrasonographic study of the thyroid gland was performed. Results Compared with patients not receiving lithium, lithium‐treated patients had significantly higher concentrations of TSH and fT4 and the lower concentration of fT3. However, the percentage of hypothyroidism was not different in both groups. Lithium‐treated patients also had significantly higher thyroid volume, the higher number of focal changes 1 cm, and more frequent goiter. The structural changes were not related to the hormones' concentrations. Conclusions The results show a significant association between long‐term lithium treatment and the increase of TSH and fT4, the decrease of fT3, higher thyroid volume, and more frequent goiter and nodular goiter. The effect of lithium on thyroid structure was not associated with its effect on thyroid hormones.
机译:摘要目的研究的目的比较甲状腺的结构和功能在双相情感障碍患者(BD)接收长期锂治疗,双相障碍患者从不接受锂。患者(68名女性和男性30日),62±13岁年,接受锂3-47年(平均19±10年),39例(27岁女性和12男性),享年57±10年,接受其他情绪稳定药物但从未接受锂,都包括在内。激素(TSH)、游离三碘甲状腺氨酸(发生)游离甲状腺素(fT4)估计,甲状腺的超声研究执行。接收锂,锂治疗患者TSH浓度显著升高fT4和低浓度的发生。甲状腺功能减退的百分比不是不同的两组。患者也明显高于甲状腺体积,更多的焦点的变化在1厘米,和更频繁的甲状腺肿。变化与激素的浓度。长期锂之间的显著联系治疗和TSH、fT4的增加减少发生,提高甲状腺体积,以及更多频繁的甲状腺肿和结节性甲状腺肿。锂在甲状腺结构无关对甲状腺激素的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号